Artia Global Partners »

Poseida Therapeutics I shares owned by Artia Global Partners

Quarter-by-quarter ownership of Poseida Therapeutics I (PSTX) shares owned by Artia Global Partners from 13F filings

Historical chart of Artia Global Partners investment in Poseida Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Poseida Therapeutics I held by Artia Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Poseida Therapeutics I by Artia Global Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $274k 86k 3.19

More positions owned by Artia Global Partners

Eli Lilly & Co Put Put Option
Novo-nordisk A S Adr (NVO)
Eli Lilly & Co. (LLY)
Merck & Co (MRK)
Viking Therapeutics (VKTX)
Abbvie (ABBV)
Intra Cellular Therapies (ITCI)
Argenx Se Sponsored Adr (ARGX)
Astrazeneca Sponsored Adr (AZN)
Vertex Pharmaceuticals Incorporated (VRTX)
Axsome Therapeutics (AXSM)
Ocular Therapeutix (OCUL)
Cytokinetics Com New (CYTK)
Neurocrine Biosciences (NBIX)
Disc Medicine (IRON)

View all positions for Artia Global Partners

Top funds holding Poseida Therapeutics I

FMR
Pentwater Capital Management
BlackRock
Boxer Capital
Silverarc Capital Management
Vanguard Group
Geode Capital Management
State Street Corporation
Aisling Capital Management
William Blair $ Company
Jacobs Levy Equity Management
Octagon Capital Advisors
Millennium Management
Atom Investors
Dimensional Fund Advisors

View all funds holding Poseida Therapeutics I